3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
2
Completed
2
Terminated
1
Suspended
1
Active not recruiting
1
Sponsor Class
OTHER
59
INDUSTRY
29
NIH
7
NETWORK
6
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
1
Interventions
Gemcitabine
4
Cisplatin
4
Rituximab
2
Fluorouracil
2
Everolimus
2
tislelizumab
1
phosphorylethanolamine
1
parsaclisib
1
human papillomavirus vaccine, L1 type 16, 18
1
famitinib
1
dalpiciclib
1
Zinc Sulfate
1
Zinc
1
Vitamin B 6
1
Tamoxifen
1
Sunitinib
1
Sorafenib
1
Radiotherapy, Adjuvant
1
Pyridoxine
1
Proton Pump Inhibitors
1
Prednisone
1
Platelet Transfusion
1
Photochemotherapy
1
Pemetrexed
1
Patient Portals
1
Paclitaxel
1
Oxaliplatin
1
Neoadjuvant Therapy
1
N-hydroxy-4-acetylaminostilbene
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
OTHER_GOV
×
Prednisone
×
Clear all
NCT02773550
2020-01-18
Velcadito
Basque Health Service
Phase 4
Terminated
24 enrolled